Sherry Heldens

5.5k total citations · 2 hit papers
6 papers, 3.8k citations indexed

About

Sherry Heldens is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Sherry Heldens has authored 6 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 2 papers in Molecular Biology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Sherry Heldens's work include Immune Response and Inflammation (2 papers), T-cell and B-cell Immunology (2 papers) and Protein Kinase Regulation and GTPase Signaling (1 paper). Sherry Heldens is often cited by papers focused on Immune Response and Inflammation (2 papers), T-cell and B-cell Immunology (2 papers) and Protein Kinase Regulation and GTPase Signaling (1 paper). Sherry Heldens collaborates with scholars based in United States, Russia and Germany. Sherry Heldens's co-authors include Vishva M. Dixit, Wyne P. Lee, Mohamed Lamkanfi, Yan Qu, Jinfeng Liu, Jennifer J. Dong, Nobuhiko Kayagaki, Salina Louie, Lieselotte Vande Walle and Kim Newton and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Sherry Heldens

6 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Non-canonical inflammasome activation targets caspase-11

2011 2.0k citations Nobuhiko Kayagaki, Søren Warming et al. Nature profile →
Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib

2005 1.2k citations David A. Eberhard, Bruce E. Johnson et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sherry Heldens United States	6	2.4k	1.3k	1.0k	1.0k	395	6	3.8k
Philipp J. Jost Germany	27	2.5k 1.1×	1.6k 1.2×	465 0.4×	863 0.8×	808 2.0×	108	4.5k
Jon Jones Germany	22	2.4k 1.0×	1.1k 0.8×	722 0.7×	902 0.9×	783 2.0×	52	3.8k
Takeshi Kondo Japan	30	1.7k 0.7×	1.1k 0.8×	291 0.3×	1.0k 1.0×	327 0.8×	168	3.9k
Andrea Abati United States	38	1.1k 0.5×	818 0.6×	945 0.9×	1.9k 1.8×	465 1.2×	97	4.6k
Maurizio Zanetti United States	36	1.5k 0.6×	2.4k 1.8×	199 0.2×	780 0.8×	308 0.8×	158	4.1k
Zoltán Lászik United States	27	998 0.4×	1.0k 0.8×	500 0.5×	399 0.4×	127 0.3×	87	3.9k
Patricia Fetsch United States	35	1.3k 0.6×	967 0.7×	752 0.7×	2.1k 2.0×	330 0.8×	73	3.9k
Isabelle Rooney United States	25	1.0k 0.4×	1000 0.7×	374 0.4×	618 0.6×	151 0.4×	49	2.5k
Wolfgang Herr Germany	34	1.4k 0.6×	2.1k 1.6×	278 0.3×	1.6k 1.5×	175 0.4×	187	4.2k
Grzegorz Dworacki Poland	23	765 0.3×	1.3k 0.9×	221 0.2×	885 0.9×	315 0.8×	99	2.6k

Countries citing papers authored by Sherry Heldens

Since Specialization

Citations

This map shows the geographic impact of Sherry Heldens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Heldens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Heldens more than expected).

Fields of papers citing papers by Sherry Heldens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherry Heldens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Heldens. The network helps show where Sherry Heldens may publish in the future.

Co-authorship network of co-authors of Sherry Heldens

This figure shows the co-authorship network connecting the top 25 collaborators of Sherry Heldens. A scholar is included among the top collaborators of Sherry Heldens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherry Heldens. Sherry Heldens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Hatzivassiliou, Georgia, Bonnie Liu, Carol O’Brien, et al.. (2012). ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors. Molecular Cancer Therapeutics. 11(5). 1143–1154. 155 indexed citations

2.

Kayagaki, Nobuhiko, Søren Warming, Mohamed Lamkanfi, et al.. (2011). Non-canonical inflammasome activation targets caspase-11. Nature. 479(7371). 117–121. 2015 indexed citations breakdown →

3.

Misaghi, Shahram, Christopher Garris, Yonglian Sun, et al.. (2010). Increased Targeting of Donor Switch Region and IgE in Sγ1-Deficient B Cells. The Journal of Immunology. 185(1). 166–173. 14 indexed citations

4.

Eberhard, David A., Bruce E. Johnson, Lukas C. Amler, et al.. (2005). Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib. Journal of Clinical Oncology. 23(25). 5900–5909. 1200 indexed citations breakdown →

5.

Li, Hanzhong, Jian Chen, Arthur Huang, et al.. (2000). Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proceedings of the National Academy of Sciences. 97(2). 773–778. 284 indexed citations

6.

Gurney, Austin, Scot A. Marsters, Arthur Huang, et al.. (1999). Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Current Biology. 9(4). 215–218. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact